BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 22693641)

  • 1. ACE2 deficiency enhances angiotensin II-mediated aortic profilin-1 expression, inflammation and peroxynitrite production.
    Jin HY; Song B; Oudit GY; Davidge ST; Yu HM; Jiang YY; Gao PJ; Zhu DL; Ning G; Kassiri Z; Penninger JM; Zhong JC
    PLoS One; 2012; 7(6):e38502. PubMed ID: 22693641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of angiotensin-converting enzyme 2 exacerbates renal inflammation and injury in apolipoprotein E-deficient mice through modulation of the nephrin and TNF-alpha-TNFRSF1A signaling.
    Jin HY; Chen LJ; Zhang ZZ; Xu YL; Song B; Xu R; Oudit GY; Gao PJ; Zhu DL; Zhong JC
    J Transl Med; 2015 Aug; 13():255. PubMed ID: 26245758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac protective effects of irbesartan via the PPAR-gamma signaling pathway in angiotensin-converting enzyme 2-deficient mice.
    Zhang ZZ; Shang QH; Jin HY; Song B; Oudit GY; Lu L; Zhou T; Xu YL; Gao PJ; Zhu DL; Penninger JM; Zhong JC
    J Transl Med; 2013 Sep; 11():229. PubMed ID: 24067190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2.
    Zhong J; Guo D; Chen CB; Wang W; Schuster M; Loibner H; Penninger JM; Scholey JW; Kassiri Z; Oudit GY
    Hypertension; 2011 Feb; 57(2):314-22. PubMed ID: 21189404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit.
    Bodiga S; Zhong JC; Wang W; Basu R; Lo J; Liu GC; Guo D; Holland SM; Scholey JW; Penninger JM; Kassiri Z; Oudit GY
    Cardiovasc Res; 2011 Jul; 91(1):151-61. PubMed ID: 21285291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme 2 attenuates oxidative stress and VSMC proliferation via the JAK2/STAT3/SOCS3 and profilin-1/MAPK signaling pathways.
    Song B; Jin H; Yu X; Zhang Z; Yu H; Ye J; Xu Y; Zhou T; Oudit GY; Ye JY; Chen C; Gao P; Zhu D; Penninger JM; Zhong JC
    Regul Pept; 2013 Aug; 185():44-51. PubMed ID: 23816468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin-converting enzyme 2 is a critical determinant of angiotensin II-induced loss of vascular smooth muscle cells and adverse vascular remodeling.
    Patel VB; Zhong JC; Fan D; Basu R; Morton JS; Parajuli N; McMurtry MS; Davidge ST; Kassiri Z; Oudit GY
    Hypertension; 2014 Jul; 64(1):157-64. PubMed ID: 24799609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of angiotensin-converting enzyme-2 exacerbates diabetic cardiovascular complications and leads to systolic and vascular dysfunction: a critical role of the angiotensin II/AT1 receptor axis.
    Patel VB; Bodiga S; Basu R; Das SK; Wang W; Wang Z; Lo J; Grant MB; Zhong J; Kassiri Z; Oudit GY
    Circ Res; 2012 May; 110(10):1322-35. PubMed ID: 22474255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced angiotensin II-induced cardiac and aortic remodeling in ACE2 knockout mice.
    Alghamri MS; Weir NM; Anstadt MP; Elased KM; Gurley SB; Morris M
    J Cardiovasc Pharmacol Ther; 2013 Mar; 18(2):138-51. PubMed ID: 23043153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction.
    Kassiri Z; Zhong J; Guo D; Basu R; Wang X; Liu PP; Scholey JW; Penninger JM; Oudit GY
    Circ Heart Fail; 2009 Sep; 2(5):446-55. PubMed ID: 19808375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotective effects mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin 1-7 in experimental heart failure in angiotensin-converting enzyme 2-null mice.
    Patel VB; Bodiga S; Fan D; Das SK; Wang Z; Wang W; Basu R; Zhong J; Kassiri Z; Oudit GY
    Hypertension; 2012 Jun; 59(6):1195-203. PubMed ID: 22508831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice.
    Oudit GY; Kassiri Z; Patel MP; Chappell M; Butany J; Backx PH; Tsushima RG; Scholey JW; Khokha R; Penninger JM
    Cardiovasc Res; 2007 Jul; 75(1):29-39. PubMed ID: 17499227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.
    Sahara M; Ikutomi M; Morita T; Minami Y; Nakajima T; Hirata Y; Nagai R; Sata M
    Cardiovasc Res; 2014 Feb; 101(2):236-46. PubMed ID: 24193738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of angiotensin-converting enzyme 2 enhances TGF-β/Smad-mediated renal fibrosis and NF-κB-driven renal inflammation in a mouse model of obstructive nephropathy.
    Liu Z; Huang XR; Chen HY; Penninger JM; Lan HY
    Lab Invest; 2012 May; 92(5):650-61. PubMed ID: 22330342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of angiotensin-converting enzyme 2 exacerbates myocardial injury via activation of the CTGF-fractalkine signaling pathway.
    Song B; Zhang ZZ; Zhong JC; Yu XY; Oudit GY; Jin HY; Lu L; Xu YL; Kassiri Z; Shen WF; Gao PJ; Zhu DL
    Circ J; 2013; 77(12):2997-3006. PubMed ID: 24161906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible role of angiotensin-converting enzyme 2 and activation of angiotensin II type 2 receptor by angiotensin-(1-7) in improvement of vascular remodeling by angiotensin II type 1 receptor blockade.
    Ohshima K; Mogi M; Nakaoka H; Iwanami J; Min LJ; Kanno H; Tsukuda K; Chisaka T; Bai HY; Wang XL; Ogimoto A; Higaki J; Horiuchi M
    Hypertension; 2014 Mar; 63(3):e53-9. PubMed ID: 24379178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telmisartan attenuates aortic hypertrophy in hypertensive rats by the modulation of ACE2 and profilin-1 expression.
    Zhong JC; Ye JY; Jin HY; Yu X; Yu HM; Zhu DL; Gao PJ; Huang DY; Shuster M; Loibner H; Guo JM; Yu XY; Xiao BX; Gong ZH; Penninger JM; Oudit GY
    Regul Pept; 2011 Jan; 166(1-3):90-7. PubMed ID: 20854846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme 2 deficiency in whole body or bone marrow-derived cells increases atherosclerosis in low-density lipoprotein receptor-/- mice.
    Thatcher SE; Zhang X; Howatt DA; Lu H; Gurley SB; Daugherty A; Cassis LA
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):758-65. PubMed ID: 21252069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective role of ACE2-Ang-(1-7)-Mas in myocardial fibrosis by downregulating K
    Wang LP; Fan SJ; Li SM; Wang XJ; Gao JL; Yang XH
    Pflugers Arch; 2016 Nov; 468(11-12):2041-2051. PubMed ID: 27592222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of ACE2 deficiency and oxidative stress on cerebrovascular function with aging.
    Peña Silva RA; Chu Y; Miller JD; Mitchell IJ; Penninger JM; Faraci FM; Heistad DD
    Stroke; 2012 Dec; 43(12):3358-63. PubMed ID: 23160880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.